Latest Financials News

Santos Limited reported robust Q3 2025 results, highlighted by the Barossa LNG project commencing production and Pikka phase 1 nearing first oil. The company’s diversified portfolio and operational discipline underpin a confident outlook despite some operational delays.

TrivarX Limited has resumed trading on the ASX following the announcement of a significant acquisition and a fresh capital raising, signaling a pivotal moment for the biotech company.

Mayne Pharma has won a key legal battle against Cosette Pharmaceuticals, clearing the way for its acquisition scheme to proceed pending final approvals. Shareholders can expect the deal to move forward with payments scheduled soon.

Genesis Minerals delivered a record 72,878 ounces of gold in the September quarter, surpassing guidance and generating a robust A$166 million cash build. The company’s ASPIRE 400 growth strategy advances with key approvals and exploration success, setting the stage for sustained expansion.

Strickland Metals has confirmed significant up-dip extensions of high-grade gold mineralisation at its Shanac Deposit within the Rogozna Project in Serbia, highlighting promising near-surface zones for early mine development.

Ionic Rare Earths has expanded its capital raising to $15.6 million, driven by a $3 million strategic investment from US firm Argentem Creek Partners and strong shareholder support. The funds will accelerate projects across magnet recycling, rare earth refining, and US supply chain development.

Bannerman Energy reports solid progress at its Etango Uranium Project, securing initial offtake agreements and maintaining robust financial health as it targets a Final Investment Decision within the next year.

Hazer Group has received a $4.58 million R&D tax incentive refund for FY25, reinforcing its financial position as it advances its methane pyrolysis technology towards commercialisation.

Bannerman Energy Ltd reported a robust cash position of AUD 111.76 million at the end of September 2025, underpinning an estimated 13.5 quarters of operational funding despite ongoing exploration expenditures.

Orezone Gold Corporation reported solid Q3-2025 gold production amid weather challenges and is on track to commission its stage 1 hard rock expansion at Bomboré, aiming for a significant production increase next year.

Metro Mining Limited achieved record quarterly bauxite shipments with improved cost efficiency, yet a recent operational outage and river constraints have prompted a downward revision of its 2025 production forecast.

Aroa Biosurgery delivered a robust September quarter with strong cash flow and record sales of its Myriad product, while reaffirming its FY26 revenue and EBITDA guidance. The company also highlighted a promising US Medicare reimbursement proposal for its Symphony product.